Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant LAG3 antibody

LAG3 Reactivity: Mouse IP, FACS, BP Host: Rat Monoclonal C9B7W unconjugated Recombinant Antibody
Catalog No. ABIN7072736
  • Target See all LAG3 Antibodies
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Antibody Type
    Recombinant Antibody
    Reactivity
    • 101
    • 29
    • 9
    • 3
    • 3
    • 3
    • 1
    • 1
    Mouse
    Host
    • 58
    • 42
    • 4
    • 3
    • 2
    • 1
    Rat
    Clonality
    • 55
    • 52
    • 2
    Monoclonal
    Conjugate
    • 66
    • 7
    • 6
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This LAG3 antibody is un-conjugated
    Application
    • 79
    • 45
    • 43
    • 34
    • 32
    • 30
    • 14
    • 13
    • 12
    • 11
    • 10
    • 9
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    Immunoprecipitation (IP), Flow Cytometry (FACS), Blocking Peptide (BP)
    Purpose
    Anti-LAG-3 [C9B7W], Rat IgG1, kappa
    Specificity
    This antibody is specific for an epitope in the D2 domain of murine LAG-3.
    Characteristics

    Original Species of Ab: Rat

    Original Format of Ab: IgG1

    Purification
    Protein A affinity purified
    Immunogen
    This antibody was raised by immunising Lewis rats with a murine LAG-3:Ig fusion protein.
    Clone
    C9B7W
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product LAG3 Primary Antibody
  • Application Notes
    This antibody has been used in flow cytometric analysis of splenocytes (Workman et al, 2005), T cell hybridomas expressing wild-type or chimeric CD4:murine LAG-3 (Workman et al, 2002) and CD4+ regulatory T cells (Chien et al, 2017). It has also been used in immunoprecipitation analysis of murine T hybridoma 3A9 cells transduced with murine LAG-3 (Li et al, 2004). This antibody blocks LAG-3 function in vitro, inhibiting antigen-induced IL-2 production in LAG-3-expressing T cell hybridomas, but does not block LAG-3:MHC class II interaction (Workman et al, 2002). Treatment with this antibody also blocks LAG-3 function in vivo, leading to accelerated homeostatic expansion of WT T cells (Workman et al, 2005). Administration of this LAG-3-blocking antibody, in combination with PD-L1 blockade, synergistically improves the survival of lymphodepleted myeloma-bearing mice (Jing et al, 2015).
    Restrictions
    For Research Use only
  • Concentration
    1 mg/mL
    Buffer
    PBS with 0.02 % Proclin 300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Alternative Name
    Lag3 (LAG3 Products)
    Background
    CD223, LAG3, Lymphocyte activation gene 3 protein
    UniProt
    Q61790
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here:
Chat with us!